greeksoup/ stock research
Stock research / United States / Funds / Mak Capital One LLC

Mak Capital One LLC

CIK 1385702 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Mak Capital One LLC reported 17 US-listed holdings worth $713.8 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Agilysys Inc. (17.5%), Grupo Financiero Galicia S A (10.4%) and Acadia Healthcare Company, Inc. (10.1%). Against the quarter before, it opened 1 position, added to 6, trimmed 3 and sold out of 5.

Reported holdings$713.8M+18.1% on Q1 2026
Positions17-4 on Q1 2026
The largest ten82.5%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedAdded toHeldTrimmed
AGYS17.5%GGAL10.4%ACHC10.1%QURE8.0%SKY7.8%AUTL7.5%CLPT5.9%SUPV5.8%CAI4.8%ANNX4.7%LAB3.3%LODE3.0%CYRX2.8%HNST2.4%3 more5.9%

The 14 largest of its 17 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $489.4 million in 10 positions$489MQ3 24Q4 2024: $522.3 million in 8 positions$522MQ4 24Q1 2025: $470.2 million in 8 positions$470MQ1 25Q2 2025: $566.7 million in 14 positions$567MQ2 25Q3 2025: $501.3 million in 12 positions$501MQ3 25Q4 2025: $743.2 million in 21 positions$743MQ4 25Q1 2026: $604.3 million in 21 positions$604MQ1 26Q2 2026: $713.8 million in 17 positions$714MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +9.8% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
90105120135Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +9.8%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 1Added 6Held 7Trimmed 3Sold out 5
Opened: 1Added: 6Held: 7Trimmed: 3Sold out: 5

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 1

  1. Caris Life Sciences Inc. CAI$34.5 million

Added to 6

  1. Uniqure NV QURE+790,846 shares · +179%
  2. Clearpoint Neuro Inc. CLPT+474,372 shares · +25%
  3. Annexon Inc. ANNX+1.1 million shares · +24%
  4. Grupo Financiero Galicia S A GGAL+56,800 shares · +4%
  5. Standard Biotools Inc. LAB+2.6 million shares · +10%
  6. Perma-Fix Environmental Svcs PESI+114,285 shares · +12%

Trimmed 3

  1. Champion Homes, Inc. SKY-650,000 shares · -51%
  2. Comstock Inc. LODE-573,552 shares · -10%
  3. Cryoport Inc. CYRX-145,906 shares · -10%

Sold out of 5

  1. Coursera Inc. COUR$32.7 million last quarter
  2. Udemy Inc. UDMY$16.9 million last quarter
  3. Protalix Biotherapeutics Inc. PLX$7.7 million last quarter
  4. Fiverr Intl Ltd FVRR$806,400 last quarter
  5. Sangamo Therapeutics, Inc. SGMOQ$138,644 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Agilysys Inc. AGYS1.2M$124.6 million17.46%no change
Grupo Financiero Galicia S A GGAL1.5M$74.3 million10.41%+56.8K
Acadia Healthcare Company, Inc. ACHC2.4M$71.8 million10.07%no change
Uniqure NV QURE1.2M$56.7 million7.95%+790.8K
Champion Homes, Inc. SKY632.4K$55.7 million7.81%-650.0K
Autolus Therapeutics PLC AUTL33.6M$53.8 million7.54%no change
Clearpoint Neuro Inc. CLPT2.4M$42.4 million5.94%+474.4K
Grupo Supervielle S A SUPV4.2M$41.1 million5.75%no change
Caris Life Sciences Inc. CAI1.9M$34.5 million4.84%new
Annexon Inc. ANNX5.9M$33.5 million4.69%+1.1M
Standard Biotools Inc. LAB28.8M$23.7 million3.32%+2.6M
Comstock Inc. LODE5.2M$21.6 million3.02%-573.6K
Cryoport Inc. CYRX1.3M$20.1 million2.81%-145.9K
Honest Co. Inc. HNST4.8M$17.5 million2.45%no change
Cenovus Energy Inc. CVE536.8K$16.2 million2.27%no change
Perma-Fix Environmental Svcs PESI1.0M$14.8 million2.07%+114.3K
Yatra Online Inc. YTRA12.2M$11.5 million1.61%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 5 it sold out of are in the box above.